| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 30 |
| 1 | METHOTREXATE SODIUM | 27 |
| 2 | FINGOLIMOD HCL | 25 |
| 3 | ADALIMUMAB | 24 |
| 4 | METHOTREXATE | 24 |
| 5 | SILDENAFIL CITRATE | 24 |
| 6 | ETANERCEPT | 20 |
| 7 | DEXAMETHASONE | 19 |
| 8 | DEXAMETHASONE 1.5 MG | 19 |
| 9 | LENALIDOMIDE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIMIPRAMINE | 3 | 0.0027 |
| 1 | FINGOLIMOD HYDROCHLORIDE | 10 | 0.0020 |
| 2 | CALCIPOTRIENE | 5 | 0.0014 |
| 3 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 4 | ACITRETIN | 3 | 0.0006 |
| 5 | VEMURAFENIB | 6 | 0.0005 |
| 6 | ALFUZOSIN HYDROCHLORIDE | 1 | 0.0004 |
| 7 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 8 | EVEROLIMUS TABLETS | 6 | 0.0004 |
| 9 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 47 |
| 1 | Corticosteroid [EPC] | 43 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 24 |
| 3 | Thalidomide Analog [EPC] | 18 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 5 | Kinase Inhibitor [EPC] | 14 |
| 6 | Interleukin-17A Antagonist [EPC] | 12 |
| 7 | Proteasome Inhibitor [EPC] | 11 |
| 8 | Purine Antimetabolite [EPC] | 11 |
| 9 | Interleukin-23 Antagonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 10 | 0.0007 |
| 1 | Interleukin-17A Antagonist [EPC] | 12 | 0.0003 |
| 2 | Vitamin D Analog [EPC] | 5 | 0.0003 |
| 3 | Nonergot Dopamine Agonist [EPC] | 3 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 5 | Recombinant Human Growth Hormone [EPC] | 3 | 0.0001 |
| 6 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Purine Antimetabolite [EPC] | 11 | 0.0001 |
| 8 | Androgen [EPC] | 3 | 0.0001 |
| 9 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |